We found that the polysaccharide H-1-2 suppresses pancreatic cancer by inhibiting hypoxia-induced AGR2 expression, supporting further investigation into its efficacy against pancreatic cancer in clinical settings. The gene discussed is AGR2; the disease is familial pancreatic carcinoma.